KARBE FRANK

CIK 00012767005 companiesFLORHAM PARK, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001276700

Recent Transactions

22 trades

Tax Payment
Cidara Therapeutics, Inc.$CDTX
Common Stock
2025-12-10$219.60/sh−7,290→ 50,562 total
Purchase
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2024-12-13$7.93/sh+12,500→ 57,000 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2024-05-29$10.16/sh+25,000→ 44,500 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2024-05-23+10,500→ 19,500 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2024-05-23−17,500→ 17,500 total
Award
Better Therapeutics, Inc.
Common Stock
2023-12-18+62,500→ 526,516 total
Purchase
Better Therapeutics, Inc.
Common Stock
2023-07-27$0.73/sh+137,005→ 429,429 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2023-05-25+9,000→ 9,000 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2023-05-25+15,000→ 15,000 total
Purchase
Better Therapeutics, Inc.
Common Stock
2023-04-10$0.82/sh+242,424→ 292,424 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2022-05-25+10,000→ 10,000 total
Exercise/Conversion
Myovant Sciences Ltd.
Common Shares
2020-09-15$5.11/sh+750→ 164,220 total
Sale
Myovant Sciences Ltd.
Common Shares
2020-09-15$21.73/sh−750→ 163,470 total
Exercise/Conversion
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2020-09-15−750→ 199,394 total
Exercise/Conversion
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2020-08-31−21,150→ 200,144 total
Exercise/Conversion
Myovant Sciences Ltd.
Common Shares
2020-08-31$5.11/sh+21,150→ 184,620 total
Sale
Myovant Sciences Ltd.
Common Shares
2020-08-31$20.01/sh−21,150→ 163,470 total
Exercise/Conversion
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2020-08-28−3,650→ 221,294 total
Exercise/Conversion
Myovant Sciences Ltd.
Common Shares
2020-08-28$5.11/sh+3,650→ 167,120 total
Sale
Myovant Sciences Ltd.
Common Shares
2020-08-28$20.04/sh−3,650→ 163,470 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2006-12-08+100,000→ 100,000 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2004-12-13+85,000→ 85,000 total

Companies

Recent Filings

Address

C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102

FLORHAM PARK, NJ, 07932

View on SEC.gov